Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

BIOTRONIK Launches First And Only 42 Joule Ultra-High Energy ICD For Heart Failure Patients

November 9, 2016 By BIOTRONIK

(Photo Credit” BIOTRONIK)

BIOTRONIK today announced the launch of Inventra HF-T, the first and only implantable cardioverter defibrillator (ICD) available in the United States that delivers an “ultra-high” energy with 42 joules (J) on the first shock. Inventra is an ICD designed for heart failure patients known as a cardiac resynchronization therapy defibrillator (CRT-D).

For many patients suffering from tachycardia (fast arrhythmias), an ICD is necessary to convert dangerous arrhythmias to a normal heart rhythm. ICDs provide life-saving shocks to the heart as needed. Patient anatomy and health conditions impact the heart’s response to shock therapy. To save lives, it is critical for an ICD to deliver an effectively powerful shock as soon as possible.

“For an increasing number of patients – specifically those with larger cardiac anatomy and lower ejection fraction – a shock that is higher than the standard 36-37 J may be needed to convert irregular arrhythmia,” said Dr. Mark Mascarenhas, electrophysiologist at Jersey Shore University Medical Center in Neptune, New Jersey. “The sooner an effective shock can be delivered, the likelihood of survival increases for these patients. For such patients, a CRT-D that delivers ultra-high energy on the first shock has a higher chance of converting the irregular arrhythmia. With the availability of Inventra HF-T, more heart failure patients will be able to receive 42 J energy delivered upon the first shock and, hence, receive life-saving therapy.”

BIOTRONIK’s Inventra line of ICDs currently includes Inventra HF-T and Inventra DX. BIOTRONIK’s DX system offers dual-chamber diagnostics with one specialized defibrillator lead, benefiting patients with minimized risk and expense.

“We invest significantly in research and development focused on advancements that improve patient lives and reduce risks, for the patient and the provider,” said Marlou Janssen, President, BIOTRONIK, Inc. “Within the industry, BIOTRONIK stands out for its commitment to the principle of vertical integration. This means we design, develop and manufacture all critical components in house. The Inventra HF-T QP is the latest example of our dedication to producing devices of the highest quality and safety, as it is uniquely able to provide 42 J of energy at first shock without compromising battery longevity. I am proud that for the first time, heart failure ICD patients in the US can receive ultra-high energy therapy when needed.”

Related Articles Read More >

A portrait of Dr. Philip Adamson
Expect more heart and lung failure years after COVID, Abbott’s heart failure CMO says
iRhythm stays silent on federal grand jury subpoenas
iRhythm stock soars on Street-beating Q1
A Medtronic HVAD pump opened up to show the inner workings
Medtronic investigates HVAD pump welds after patient deaths

DeviceTalks Weekly.

May 20, 2022
DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech